-
Study aim
-
The therapeutic effect of thyme essential oil in patients with new corona virus infection
-
Design
-
The clinical trial has a control group and a parallel intervention group, blinded, randomized to 100 patients. For randomization, the table of random numbers based on online software (Kit Set) has been used.
-
Settings and conduct
-
In this study, patients will be selected from 18-50 year olds whose corona tests were positive and hospitalized in Valiasr Hospital, Zanjan, Iran. The number of people studied in each group is 50. This study includes two groups: Control group: Patients with covid19 who do not receive any other drug (thyme essential oil) except the drug protocol. Intervention group: Patients with covid 19 who, in addition to medication, receive thyme essential oil according to the protocol.
It is prepared as a syrup (made from the essence of 10% of thyme). Each patient takes three doses a day, 5 cc each, for one week. Evaluation of results and effectiveness after taking the drug (thyme syrup), fever, cough, runny nose, shortness of breath, headache, muscle aches, sore throat, anorexia, fatigue, weakness and lethargy.
-
Participants/Inclusion and exclusion criteria
-
Entry criteria: COVID 19 Patients 50-18 years of age in the rehabilitation center.
Exclusion criteria: respiratory diseases; pregnant women; allergic diseases and dissatisfaction with participation in the study.
-
Intervention groups
-
Intervention Group 1: In addition to receiving medication based on the treatment protocol, 15 cc of syrup containing 10% thyme essential oil is given daily in three divided doses for one week.
Intervention Group 2: They only receive medication based on the treatment protocol.
-
Main outcome variables
-
Thyme may be able to speed up the healing of fever, cough, runny nose, shortness of breath, headache, muscle aches, sore throat, anorexia, fatigue, weakness and lethargy.